These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 28410131)

  • 1. Substance use disorder a bio-directional subset of reward deficiency syndrome.
    Blum K; Gold M; Demetrovics Z; Archer T; Thanos PK; Baron D; Badgaiyan RD
    Front Biosci (Landmark Ed); 2017 Jun; 22(9):1534-1548. PubMed ID: 28410131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overcoming qEEG abnormalities and reward gene deficits during protracted abstinence in male psychostimulant and polydrug abusers utilizing putative dopamine D₂ agonist therapy: part 2.
    Blum K; Chen TJ; Morse S; Giordano J; Chen AL; Thompson J; Allen C; Smolen A; Lubar J; Stice E; Downs BW; Waite RL; Madigan MA; Kerner M; Fornari F; Braverman ER
    Postgrad Med; 2010 Nov; 122(6):214-26. PubMed ID: 21084796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute intravenous synaptamine complex variant KB220™ "normalizes" neurological dysregulation in patients during protracted abstinence from alcohol and opiates as observed using quantitative electroencephalographic and genetic analysis for reward polymorphisms: part 1, pilot study with 2 case reports.
    Miller DK; Bowirrat A; Manka M; Miller M; Stokes S; Manka D; Allen C; Gant C; Downs BW; Smolen A; Stevens E; Yeldandi S; Blum K
    Postgrad Med; 2010 Nov; 122(6):188-213. PubMed ID: 21084795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuro-chemical activation of brain reward meso-limbic circuitry is associated with relapse prevention and drug hunger: a hypothesis.
    Blum K; Gold MS
    Med Hypotheses; 2011 Apr; 76(4):576-84. PubMed ID: 21306831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular neurological correlates of endorphinergic/dopaminergic mechanisms in reward circuitry linked to endorphinergic deficiency syndrome (EDS).
    Blum K; Baron D; McLaughlin T; Gold MS
    J Neurol Sci; 2020 Apr; 411():116733. PubMed ID: 32088516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Manipulation of catechol-O-methyl-transferase (COMT) activity to influence the attenuation of substance seeking behavior, a subtype of Reward Deficiency Syndrome (RDS), is dependent upon gene polymorphisms: a hypothesis.
    Blum K; Chen TJ; Meshkin B; Waite RL; Downs BW; Blum SH; Mengucci JF; Arcuri V; Braverman ER; Palomo T
    Med Hypotheses; 2007; 69(5):1054-60. PubMed ID: 17467918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-related cognitive impairment shows bi-directional association with dopamine receptor DRD1 and DRD2 polymorphisms in substance-dependent and substance-independent populations.
    Jacobs MM; Murray J; Byrd DA; Hurd YL; Morgello S
    J Neurovirol; 2013 Oct; 19(5):495-504. PubMed ID: 24078558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypothesizing That Neuropharmacological and Neuroimaging Studies of Glutaminergic-Dopaminergic Optimization Complex (KB220Z) Are Associated With "Dopamine Homeostasis" in Reward Deficiency Syndrome (RDS).
    Blum K; Febo M; Fried L; Li M; Dushaj K; Braverman ER; McLaughlin T; Steinberg B; Badgaiyan RD
    Subst Use Misuse; 2017 Mar; 52(4):535-547. PubMed ID: 28033474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Putative COVID- 19 Induction of Reward Deficiency Syndrome (RDS) and Associated Behavioral Addictions with Potential Concomitant Dopamine Depletion: Is COVID-19 Social Distancing a Double Edged Sword?
    Blum K; Cadet JL; Baron D; Badgaiyan RD; Brewer R; Modestino EJ; Gold MS
    Subst Use Misuse; 2020; 55(14):2438-2442. PubMed ID: 32957797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Heterodimeric D1-D2 dopamine receptors: a review].
    Vekshina NL; Anokhin PK; Veretinskaya AG; Shamakina IY
    Biomed Khim; 2017 Jan; 63(1):5-12. PubMed ID: 28251946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addiction-related alterations in D1 and D2 dopamine receptor behavioral responses following chronic cocaine self-administration.
    Edwards S; Whisler KN; Fuller DC; Orsulak PJ; Self DW
    Neuropsychopharmacology; 2007 Feb; 32(2):354-66. PubMed ID: 16541082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reward deficiency syndrome: genetic aspects of behavioral disorders.
    Comings DE; Blum K
    Prog Brain Res; 2000; 126():325-41. PubMed ID: 11105655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypodopaminergia and "Precision Behavioral Management" (PBM): It is a Generational Family Affair.
    Fried L; Modestino EJ; Siwicki D; Lott L; Thanos PK; Baron D; Badgaiyan RD; Ponce JV; Giordano J; Downs WB; Gondré-Lewis MC; Bruce S; Braverman ER; Boyett B; Blum K
    Curr Pharm Biotechnol; 2020; 21(6):528-541. PubMed ID: 31820688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. rsfMRI effects of KB220Z™ on neural pathways in reward circuitry of abstinent genotyped heroin addicts.
    Blum K; Liu Y; Wang W; Wang Y; Zhang Y; Oscar-Berman M; Smolen A; Febo M; Han D; Simpatico T; Cronjé FJ; Demetrovics Z; Gold MS
    Postgrad Med; 2015 Mar; 127(2):232-41. PubMed ID: 25526228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug addiction. Part II. Neurobiology of addiction.
    Vetulani J
    Pol J Pharmacol; 2001; 53(4):303-17. PubMed ID: 11990077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine homeostasis: brain functional connectivity in reward deficiency syndrome.
    Febo M; Blum K; Badgaiyan RD; Baron D; Thanos PK; Colon-Perez LM; Demortrovics Z; Gold MS
    Front Biosci (Landmark Ed); 2017 Jan; 22(4):669-691. PubMed ID: 27814639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased sensitivity to the effects of dopamine D1-like, but not D2-like, receptor antagonism in the posterior hypothalamic region/anterior ventral tegmental area on brain reward function during chronic exposure to nicotine in rats.
    Bruijnzeel AW; Markou A
    Brain Res; 2005 Oct; 1058(1-2):91-100. PubMed ID: 16126181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. There and back again: a tale of norepinephrine and drug addiction.
    Weinshenker D; Schroeder JP
    Neuropsychopharmacology; 2007 Jul; 32(7):1433-51. PubMed ID: 17164822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drugs of abuse-induced hyperthermia, blood-brain barrier dysfunction and neurotoxicity: neuroprotective effects of a new antioxidant compound H-290/51.
    Sharma HS; Sjöquist PO; Ali SF
    Curr Pharm Des; 2007; 13(18):1903-23. PubMed ID: 17584116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Convergent evidence from alcohol-dependent humans and rats for a hyperdopaminergic state in protracted abstinence.
    Hirth N; Meinhardt MW; Noori HR; Salgado H; Torres-Ramirez O; Uhrig S; Broccoli L; Vengeliene V; Roßmanith M; Perreau-Lenz S; Köhr G; Sommer WH; Spanagel R; Hansson AC
    Proc Natl Acad Sci U S A; 2016 Mar; 113(11):3024-9. PubMed ID: 26903621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.